NASDAQ NMS - GLOBAL MARKET · CDXS
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Codexis Inc

Codexis Inc

Life Sciences Tools & Services
$1.67
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Analyst data unavailable at compute time
CDXS
Codexis Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

66/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CDXS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CDXS catalysts
About Codexis Inc
INDUSTRIAL ORGANIC CHEMICALS
Listed since
2010
Employees
146
Country
US

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.67
Last session
Day high
$1.67
Last session
Day low
$1.67
Last session
Previous close
$1.67
52W high
$2.85
-41.40% from high
52W low
$0.9800
37% of range
Market cap
$182.9M
EPS
$-0.7000
Beta
1.73
Shares out
109.5M
Avg volume
1.4M
VWAP
$1.67
Last session
Price history computed in-house
1W
+5.03%
1M
+12.84%
3M
-35.77%
1Y
-42.11%
YTD
+2.45%
SMA 50 $2.00 · below
SMA 200 $1.90 · below
52W position 37%

CDXS overview

Veridion Score
66
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
1
Lamar Smith · Purchase
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CDXS.Congress disclosuresOpen receipt and filing context for CDXS.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CDXS Form 4 filings
Public disclosures

Congress activity in CDXS

Congress trackerOpen ticker disclosure ledger →
Federal contracts

CDXS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDXS in this window.
Lobbying spend

CDXS lobbying filings, year to date.

Registered lobbying filings matched to Codexis Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CDXS in this window.
Loading news for CDXS
Analyst ratings
Sovereign unlock shows live analyst consensus for CDXS.
Options
Sovereign unlock shows live options positioning for CDXS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.